<DOC>
	<DOCNO>NCT01362192</DOCNO>
	<brief_summary>The purpose study evaluate safety effectiveness new laser removal unsightly spider vein legs . The device use study Cutera Excel V laser , dual wavelength 532 nm potassium titanyl phosphate ( KTP ) 1064 nm neodymium-doped yttrium aluminum garnet ( Nd : YAG ) laser . The Excel V laser receive 510 ( k ) clearance FDA , mean FDA approve laser dermatological vascular condition , like spider vein .</brief_summary>
	<brief_title>Treatment Lower Extremity Spider Veins With Excel V</brief_title>
	<detailed_description>Each subject receive 532 nm KTP laser treatment low extremity spider vein least 2 , 4 , separate area . Subjects receive 2 laser treatment space 12 week apart . Subjects follow 24 week ( 12 week final laser treatment ) . Efficacy evaluate blinded independent physician assessment improvement treat spider vein use digital photograph take baseline final follow-up visit third-party medical photography service . In addition , efficacy evaluate Investigator 's mean global assessment improvement subject 's mean assessment improvement . Safety evaluate continuous monitoring adverse event ( AEs ) measure pain associate laser treatment .</detailed_description>
	<mesh_term>Telangiectasis</mesh_term>
	<mesh_term>Chlorhexidine</mesh_term>
	<mesh_term>Chlorhexidine gluconate</mesh_term>
	<criteria>Fitzpatrick Skin Type I III Having least 2 separate area measure 5cm x 5cm low extremity spider vein Having low extremity spider vein less 2.0mm diameter , linear branching , red , pink , blue and/or purple color , assess Investigator Having low extremity spider vein appropriate laser treatment , assess Investigator Subject must able read , understand sign Informed Consent Form Subject must willing able adhere treatment followup schedule posttreatment care instruction Wiling limit sun exposure duration study , include followup period Willingness digital photograph take low extremity spider vein Agree undergo procedure treatment low extremity spider vein study Willing take 'prn ' medication ache pain ( Tylenol® Advil® ) day laser treatment For female candidate postmenopausal surgically sterilize , use medically acceptable form birth control least 3 month prior enrollment entire course study Having receive prior laser treatment low extremity spider vein Fitzpatrick Skin Type IV VI Pregnant Having infection , dermatitis rash treatment area Having significant varicosity perforator vein History keloid scarring , hypertrophic scar abnormal wound heal History immunosuppression/immune deficiency disorder currently use immunosuppressive medication History connective tissue disease , systemic lupus erythematosus scleroderma History pigmentary disorder , particularly tendency hyper hypopigmentation Having know anticoagulative condition take anticoagulation medication History thromboembolic disease , deep vein thrombosis ( DVT ) History seizure disorder due light Having history disease stimulate heat , recurrent herpes simplex treatment area , unless treatment conduct follow prophylactic regimen Having undergone surgery treatment area within 6 month treatment ( skin heal completely ) Suffering significant concurrent illness , insulindependent diabetes ( type I II ) , peripheral vascular disease peripheral neuropathy Undergoing systemic chemotherapy treatment cancer Systemic use isotretinoin ( Accutane® ) within 6 month study participation Any use gold therapy disorder rheumatologic disease lupus Excessively tan area treat unable/unlikely refrain tan study Participation study another device drug within three month prior enrollment study As per Investigator 's discretion , physical mental condition might make unsafe subject participate study</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Telangiectasis</keyword>
	<keyword>Spider Veins</keyword>
	<keyword>Excel V</keyword>
	<keyword>Cutera</keyword>
	<keyword>Laser</keyword>
	<keyword>Leg Veins</keyword>
	<keyword>Venulectasia</keyword>
	<keyword>Lower Extremity vein</keyword>
	<keyword>Laser light</keyword>
	<keyword>KTP</keyword>
	<keyword>532nm</keyword>
</DOC>